sb 203580 has been researched along with oxalates in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (oxalates) | Trials (oxalates) | Recent Studies (post-2010) (oxalates) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 6,946 | 136 | 1,162 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhandari, A; Chaturvedi, LS; Koul, HK; Koul, S; Menon, M; Sekhon, A | 1 |
1 other study(ies) available for sb 203580 and oxalates
Article | Year |
---|---|
Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells.
Topics: Animals; DNA Replication; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kidney; LLC-PK1 Cells; Mitogen-Activated Protein Kinases; Oxalates; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Swine | 2002 |